Brevetti EPO No.3191120 2024.04.10
Brevetti EPO
(10) Registration Number and Date
2024000285 2024.08.12
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000285 2015.09.08
(40) Publication Number and Date
SM /T/2024/000285 2024.08.12
(30) Priority Details
US 201462048512 P
2014.09.10
(51) IPC Classes
(72) Inventor
(IT) LIGOZIO, Gregory : c/o Novartis Pharmaceuticals CorporationOne Health Plaza, East Hanover, NJ 07936, US
(IT) MPOFU, Shephard : c/o Novartis Pharma AGPostfach, 4002 Basel, CH
(IT) RICHARDS, Hanno : c/o Novartis Pharma AGPostfach, 4002 Basel, CH
(74) Representative Name
(IT) DE BENEDETTI, Jacopo : Via L. Cibrario, 25, 47893 Borgo Maggiore RSM , SM
(54) Title
(IT) USO DI ANTAGONISTI DI IL-17 PER INIBIRE LA PROGRESSIONE DEL DANNO STRUTTURALE IN PAZIENTI AFFETTI DA ARTRITE PSORIASICA
(EN) USE OF IL-17 ANTAGONISTS TO INHIBIT THE PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PATIENTS
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2024.09.17
Event NameDateStatus
Filing2015.09.08Filed
Brevetto EPO concesso2024.08.12Published
Ricevuta pagamento annualita 102024.08.28Payed